Page last updated: 2024-08-26

nicotine and taurine

nicotine has been researched along with taurine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	6 (66.67)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Satoh, H	1
Aistrup, GL; Engel, JA; Ericson, M; Hedlund, L; Kalouti, U; Marszalec, W; Narahashi, T; Nordberg, A; Olausson, P; Schmidt, LG; Smolka And, M; Söderpalm, B; Zhang, X	1
Alican, I; Cetinel, S; Cikler, E; Gedik, N; Ipçi, Y; Sehirli, O; Sener, G	1
Alican, I; Cetinel, S; Cikler, E; Gedik, N; Ipçi, Y; Ozer Sehirli, A; Sener, G	1
Beilby, JJ; Doran, CM; Duszynski, KM; Mattick, RP	1
Diehl, A; Mann, K	1
Spangler, JG	1
Bholat, Y; Farrokhi, C; Lacayo, LM; Manalo, CM; Pechnick, RN; Reyes, KC; Spivak, I; Vit, JP	1
Goutier, W; Kloeze, M; McCreary, AC	1

Reviews

2 review(s) available for nicotine and taurine

Article	Year
Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers. Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:5 Suppl IS Topics: Acamprosate; Acetylcholine; Alcohol Deterrents; Alcoholism; Animals; Central Nervous System Depressants; Drug Interactions; Ethanol; Gene Expression; Humans; Male; Nicotine; Nicotinic Agonists; Rats; Receptors, Nicotinic; Reinforcement, Psychology; Secondary Prevention; Smoking; Taurine; Vasodilator Agents; Ventral Tegmental Area	2001
[Pharmacological relapse prevention in alcohol and tobacco dependence]. Der Internist, 2007, Volume: 48, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder	2007

Article

Year

Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers.

Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:5 Suppl IS

Topics: Acamprosate; Acetylcholine; Alcohol Deterrents; Alcoholism; Animals; Central Nervous System Depressants; Drug Interactions; Ethanol; Gene Expression; Humans; Male; Nicotine; Nicotinic Agonists; Rats; Receptors, Nicotinic; Reinforcement, Psychology; Secondary Prevention; Smoking; Taurine; Vasodilator Agents; Ventral Tegmental Area

2001

[Pharmacological relapse prevention in alcohol and tobacco dependence].

Der Internist, 2007, Volume: 48, Issue:1

Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder

2007

Other Studies

7 other study(ies) available for nicotine and taurine

Article	Year
Suppressive responses to calcium and catecholamines in immobilization stress-loaded rats. General pharmacology, 1998, Volume: 30, Issue:3 Topics: Adrenergic Agonists; Animals; Calcium; Heart; Heart Atria; Isoproterenol; Male; Nicotine; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Stress, Physiological; Taurine	1998
Protective effects of taurine against nicotine-induced oxidative damage of rat urinary bladder and kidney. Pharmacology, 2005, Volume: 74, Issue:1 Topics: Animals; Antioxidants; Blood Urea Nitrogen; Collagen; Creatinine; Glutathione; In Vitro Techniques; Kidney; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Malondialdehyde; Muscle Contraction; Muscle, Smooth; Nicotine; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Taurine; Urinary Bladder	2005
Taurine treatment protects against chronic nicotine-induced oxidative changes. Fundamental & clinical pharmacology, 2005, Volume: 19, Issue:2 Topics: Animals; Aorta, Thoracic; Heart; Lipid Peroxidation; Male; Muscle, Smooth, Vascular; Myocardium; Nicotine; Nicotinic Agonists; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Taurine; Vasoconstriction	2005
Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice. Addictive behaviors, 2006, Volume: 31, Issue:11 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Bupropion; Dopamine Uptake Inhibitors; Female; Health Care Surveys; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Substance-Related Disorders; Taurine; Tobacco Use Disorder	2006
NMDA receptor blockade: a novel avenue for tobacco intervention? Medical hypotheses, 2008, Volume: 70, Issue:5 Topics: Acamprosate; Central Nervous System Stimulants; Humans; Memantine; Models, Biological; Models, Theoretical; Neurons; Nicotiana; Nicotine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Smoking Cessation; Taurine	2008
Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats. Behavioural pharmacology, 2011, Volume: 22, Issue:3 Topics: Acamprosate; Animals; Cues; Drug-Seeking Behavior; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Self Administration; Taurine	2011
Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids. Addiction biology, 2016, Volume: 21, Issue:2 Topics: Acamprosate; Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Bupropion; Dose-Response Relationship, Drug; Fructose; Indoles; Male; Motor Activity; Naltrexone; Nicotine; Nicotinic Agonists; Pyrrolidines; Rats, Wistar; Taurine; Tobacco Use Cessation Devices; Topiramate	2016